Auranofin is an effective agent against clinical isolates of Staphylococcus aureus
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Auranofin is an effective agent against clinical isolates of Staphylococcus aureus
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume -, Issue -, Pages -
Publisher
Future Science Ltd
Online
2019-07-12
DOI
10.4155/fmc-2018-0544
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Repurposing Approach Identifies Auranofin with Broad Spectrum Antifungal Activity That Targets Mia40-Erv1 Pathway
- (2017) Shankar Thangamani et al. Frontiers in Cellular and Infection Microbiology
- Screening a Commercial Library of Pharmacologically Active Small Molecules against Staphylococcus aureus Biofilms
- (2016) Nelson S. Torres et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin
- (2016) Beth Burgwyn Fuchs et al. Future Medicinal Chemistry
- Repurposing auranofin for the treatment of cutaneous staphylococcal infections
- (2016) Shankar Thangamani et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action
- (2016) Derek Parsonage et al. JOURNAL OF STRUCTURAL BIOLOGY
- Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens
- (2016) Shankar Thangamani et al. Scientific Reports
- Evidence that the antiproliferative effects of auranofin in Saccharomyces cerevisiae arise from inhibition of mitochondrial respiration
- (2015) Tania Gamberi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis
- (2015) Michael B. Harbut et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections
- (2014) Maria Iris Cassetta et al. BIOMETALS
- Infection Management and Multidrug-Resistant Organisms in Nursing Home Residents With Advanced Dementia
- (2014) Susan L. Mitchell et al. JAMA Internal Medicine
- The Changing Epidemiology of Methicillin-Resistant Staphylococcus aureus in the United States: A National Observational Study
- (2013) Eili Y. Klein et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- A Reprofiled Drug, Auranofin, Is Effective against Metronidazole-Resistant Giardia lamblia
- (2013) Noa Tejman-Yarden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The thioredoxin antioxidant system
- (2013) Jun Lu et al. FREE RADICAL BIOLOGY AND MEDICINE
- The study of pathogen resistance and antimicrobial use in dementia: Study design and methodology
- (2012) Susan L. Mitchell et al. ARCHIVES OF GERONTOLOGY AND GERIATRICS
- Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione
- (2012) Jun Lu et al. FASEB JOURNAL
- Effects of a Mitochondrial Mutator Mutation in YeastPOS5NADH Kinase on Mitochondrial Nucleotides
- (2012) Linda J. Wheeler et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Essential genes as antimicrobial targets and cornerstones of synthetic biology
- (2012) Mario Juhas et al. TRENDS IN BIOTECHNOLOGY
- Multidrug Resistance in Bacteria
- (2009) Hiroshi Nikaido Annual Review of Biochemistry
- Inhibition ofSchistosoma mansoniThioredoxin-glutathione Reductase by Auranofin
- (2009) Francesco Angelucci et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Platyhelminth Mitochondrial and Cytosolic Redox Homeostasis Is Controlled by a Single Thioredoxin Glutathione Reductase and Dependent on Selenium and Glutathione
- (2008) Mariana Bonilla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started